Cost-effective analysis of teclistamab and daratumumab versus ciltacabtagene autoleucel in relapsed multiple myeloma

Authors

• Sohaib Irfan, Aga Khan University
• M Abdullah Jamil, Aga Khan University
• Muhammad Bilal Abid, Texas Tech University Health Science Center

Document Type

Article

Department

Medical College Pakistan

Comments

Abstract, volume, issue, and pagination are not provided by the author/publisher.

Publication (Name of Journal)

Br J Haematol

DOI

10.1111/bjh.70607

Recommended Citation

Irfan, S., Jamil, M. A., Abid, M. B. (2026). Cost-effective analysis of teclistamab and daratumumab versus ciltacabtagene autoleucel in relapsed multiple myeloma. Br J Haematol.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_mc/684